Valeant Ups Takeover Bid For Allergan

Valeant sweetened its takeover bid for Botox maker Allergan, offering to buy the company for $49.4 billion.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsM&A
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!